BSE : INDOCO.BO

Indoco Remedies Limited

$242 INR

$4.45 (1.87%)

Volume
3.08K
Average Volume
2.19K
Market Capitalization
$22.44B
P/E Ratio
-22.66
Dividend Yield
0.08%
Price Target
Year High
$348.10
Year Low
$190.00
Day High
Day Low
Payout Ratio
-$0.02
Current Ratio
$1.13
Company Overview

BSE

Aditi Kare Panandikar

Drug Manufacturers - Specialty & Generic

Healthcare

INDOCO.BO

6000

IN

INR

91 22 6287 1000

N/A

N/A

Liquidity Metrics

1.16

1.13

0.75

0.03

-0.02

Sales & Valuation

$18.45B

1.23

2.18

41.52

6.42

Profitability

-$10.69

-$987M

-5.33%

-5.85%

-9.94%

-3.75%

P/E Metrics

-22.66

0.55

0.55

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Financial Health Scores

1.55

3/9

$1.41B

$25.93B

$16.61B

$120.4M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Rajan Saawant Vice President of Corporate HR
Kavita Inamdar Chief Technical Officer
Pramod Ghorpade Chief Financial Officer
Ajay Karajagi President of Sales & Marketing
Dileep Mahajan Vice President of Operations
Ramanathan Hariharan Head of Legal, Company Secretary & Compliance Officer
Aditi Milind Panandikar MD & Executive Director
Rajesh Usgaonker Chief Marketing Officer
Sundeep Vasant Bambolkar Joint MD & Executive Director
Suresh Govind Kare Non-Executive Chairman & Whole time Director
Poll Results

No votes yet today — be the first to share your view!

About Indoco Remedies Limited (BSE:INDOCO.BO) Stock

Indoco Remedies Limited, headquartered in Mumbai, India, is a diversified pharmaceutical company founded in 1945 (formerly Indo Continental Trading Company). The company specializes in the development, manufacturing, marketing, and global distribution of both active pharmaceutical ingredients (APIs) and a broad spectrum of finished drug formulations. Their extensive product portfolio addresses numerous medical fields, including oral care, digestive health, respiratory ailments, anti-infectives, nutritional supplements, ophthalmology, antifungal treatments, hormonal therapies, dermatology, urology, diabetes management, gynaecological solutions, lifestyle products, pain management, and cardiovascular medicines. Additionally, Indoco offers a diverse range of branded generic pharmaceuticals, s ... uch as analgesic tablets and topical preparations, antihypertensive medications, protein supplements, multivitamin tablets and syrups, various antibiotic forms (tablets, syrups, and injectables), oral rehydration powders, anti-haemorrhoidals, antacids, and antihistamines. Beyond its core pharmaceutical production, Indoco Remedies provides comprehensive analytical testing services. These include impurity profiling, particle size analysis, polymorphism and compatibility studies, heavy metal detection, extractables and leachables assessments, lyophilization investigations, reference and working standards development, forced degradation studies, and chromatographic method development and validation. The company also extends its expertise to a suite of engineering and project management services, encompassing architectural design, lighting, mechanical and utility engineering, project and construction management, electrical systems, control system integration, piping, structural design, data transfer systems, and process engineering solutions. Furthermore, Indoco is a key provider of contract research and manufacturing services (CRAMS). This includes custom synthesis of molecules and intermediates, advanced process chemistry research and development, designing and scaling up non-infringing processes, and developing and validating analytical methods, alongside comprehensive contract manufacturing capabilities.

Frequently Asked Questions

What is the current Indoco Remedies Limited (INDOCO.BO) stock price?

Indoco Remedies Limited(BSE:INDOCO.BO) stock price is $242 in the last trading session. During the trading session, INDOCO.BO stock reached the peak price of $348.1 while $190 was the lowest point it dropped to. The percentage change in INDOCO.BO stock occurred in the recent session was 1.87% while the dollar amount for the price change in INDOCO.BO stock was $4.45.

INDOCO.BO's industry and sector of operation?

The BSE listed INDOCO.BO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of INDOCO.BO?

Rajan Saawant | Vice President of Corporate HR
Kavita Inamdar | Chief Technical Officer
Pramod Ghorpade | Chief Financial Officer
Ajay Karajagi | President of Sales & Marketing
Dileep Mahajan | Vice President of Operations

How many employees does INDOCO.BO have?

Number of INDOCO.BO employees currently stands at 6000. INDOCO.BO operates from Indoco House, Mumbai, MA 400098, IN.

Link for INDOCO.BO official website?

Official Website of INDOCO.BO is: https://www.indoco.com

How do I contact INDOCO.BO?

INDOCO.BO could be contacted at phone #91 22 6287 1000 and can also be accessed through its website. INDOCO.BO operates from Indoco House, Mumbai, MA 400098, IN.

How many shares of INDOCO.BO are traded daily?

The average number of INDOCO.BO shares traded daily for last 3 months was 2.19K.

What is the market cap of INDOCO.BO currently?

The market value of INDOCO.BO currently stands at $22.44B with its latest stock price at $242